Articles related to MULTIPLE SCLEROSIS (MS)

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

This study of more than 1,100 MS patients reveals a significant perception of higher empathy in AI-generated responses compared to those from neurologists, underlining the potential to tailor AI communication tools to improve patient interactions.

Ensuring patient comfort during MRI scans is not just about improving the experience but also about enhancing diagnostic accuracy. Insights on optimal patient preparation, from clothing choices to personalizing auditory experiences, can lead to more effective and efficient MRI procedures.

In the evolving landscape of MS treatment, the strategic choice between early aggressive and escalation therapies is critical. Understanding the nuances of patient-specific factors, such as age and disease activity, can significantly influence outcomes and guide effective management.

In a recent phase 2 trial, frexalimab, targeting the CD40-CD40L pathway, demonstrated a notable reduction in new gadolinium-enhancing T1-weighted lesions in patients with relapsing multiple sclerosis.

At ECTRIMS-ACTRIMS 2023, pivotal studies like the OLIKOS and MIRANTIBUS trials have highlighted the evolving dynamics in MS treatment, particularly emphasizing the shift towards more patient-centric and effective therapeutic approaches.